Cannabis and Oxycodone (OxyContin)
Generic: oxycodone
Brand names: OxyContin, Percocet, Roxicodone
Important Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Do not start, stop, or modify your use of Oxycodone or cannabis without consulting your doctor or pharmacist. If you experience adverse effects, seek immediate medical attention. Individual responses to drug combinations vary significantly.
Overview
Oxycodone (OxyContin, Percocet) is a potent semi-synthetic opioid prescribed for moderate to severe pain. This combination is rated HIGH RISK because of the serious danger of enhanced respiratory depression and the significant pharmacokinetic interaction through CYP3A4. Oxycodone is metabolized primarily by CYP3A4 (to noroxycodone) and CYP2D6 (to oxymorphone), and CBD potently inhibits both of these enzymes. This can lead to substantially elevated oxycodone blood levels, increasing the risk of opioid toxicity including fatal respiratory depression. The high potency of oxycodone compared to hydrocodone makes this interaction particularly concerning. Even small increases in oxycodone plasma levels can shift a patient from the therapeutic range into a toxic range. When combined with the pharmacodynamic CNS depression from THC, the margin of safety narrows dramatically. Extended-release oxycodone formulations (OxyContin) present additional risk, as altered metabolism can lead to sustained elevated levels over many hours. The medical literature consistently identifies opioid-cannabis combinations as a significant safety concern, and this interaction should be taken seriously by all patients and providers. This information is for educational purposes only. Consult your healthcare provider.
How They Interact
Oxycodone undergoes hepatic metabolism primarily through CYP3A4 (producing noroxycodone, a weaker metabolite, accounting for approximately 45% of metabolism) and CYP2D6 (producing oxymorphone, a more potent opioid, accounting for approximately 19% of metabolism). CBD inhibits CYP3A4 (Ki ~1.6 μM) and CYP2D6 (Ki ~1.2–2.7 μM), reducing clearance through both pathways. Inhibition of CYP3A4, the major pathway, can substantially elevate oxycodone plasma concentrations. Simultaneously, reduced CYP2D6 activity decreases formation of the more potent oxymorphone metabolite, but the net opioid effect is typically increased due to markedly elevated oxycodone levels. THC produces additive respiratory depression by activating CB1 receptors in brainstem respiratory centers, which synergize with mu-opioid receptor-mediated respiratory depression at the pre-Bötzinger complex, the primary respiratory rhythm generator.
Cannabinoid-Specific Interactions
| Cannabinoid | Interaction with Oxycodone |
|---|---|
| CBD | CBD potently inhibits CYP3A4 and CYP2D6, the two primary enzymes responsible for oxycodone metabolism. This can cause substantial elevations in oxycodone plasma concentrations, potentially pushing levels from the therapeutic to toxic range. The interaction is particularly dangerous with extended-release oxycodone formulations. |
| THC | THC produces synergistic respiratory depression with oxycodone through CB1 receptor activation in brainstem respiratory centers. The combination also causes profound sedation, impaired consciousness, and psychomotor dysfunction. This pharmacodynamic synergy at respiratory control centers represents the most immediately life-threatening aspect of this interaction. |
| CBN | CBN's potent sedative effects combined with oxycodone's CNS depression create a dangerous level of sedation and respiratory compromise. CBN should be avoided entirely when taking oxycodone. |
Symptoms to Watch For
- ⚠Respiratory depression: dangerously slow, shallow, or stopped breathing
- ⚠Extreme drowsiness, stupor, or loss of consciousness
- ⚠Pinpoint pupils with cold, clammy skin
- ⚠Severe nausea, vomiting, or constipation
- ⚠Bluish discoloration of lips or fingertips (cyanosis — emergency sign)
Recommendations
- 1Do not combine cannabis with oxycodone unless under direct medical supervision with appropriate monitoring.
- 2Keep naloxone (Narcan) accessible and ensure household members know how to use it.
- 3Never use extended-release oxycodone (OxyContin) with cannabis, as CYP3A4 inhibition can cause sustained toxic levels.
- 4Report any signs of excessive sedation, confusion, or breathing changes to your physician immediately.
- 5If you find someone who has combined these substances and is difficult to arouse, call 911 immediately and administer naloxone if available.
Research Summary
The CYP3A4-mediated metabolism of oxycodone is well-characterized, and drug interaction studies with known CYP3A4 inhibitors (ketoconazole, itraconazole) have demonstrated 2–3 fold increases in oxycodone AUC. While equivalent data for CBD are not yet published in clinical trials, in vitro evidence of CBD's potent CYP3A4 inhibition suggests a comparable magnitude of interaction. The FDA label for oxycodone warns against concurrent use with CYP3A4 inhibitors, noting increased risk of respiratory depression and overdose. A 2019 pharmacovigilance analysis identified multiple case reports of enhanced opioid toxicity in patients using concurrent CBD products. Preclinical studies have confirmed synergistic respiratory depression when CB1 agonists and mu-opioid agonists are co-administered, with effects at brainstem respiratory centers. This information is for educational purposes only. Consult your healthcare provider.
Frequently Asked Questions
Can CBD oil cause an oxycodone overdose?
CBD can inhibit the enzymes that metabolize oxycodone (CYP3A4 and CYP2D6), potentially raising oxycodone blood levels to toxic ranges. While CBD alone would not cause an overdose, the elevated oxycodone levels could contribute to opioid toxicity and respiratory depression. This risk is greatest with high-dose CBD products.
Is it safe to use marijuana while on OxyContin?
No. This is a high-risk combination. Extended-release oxycodone (OxyContin) combined with cannabis is particularly dangerous because CYP3A4 inhibition by CBD can cause sustained elevation of oxycodone levels over many hours. The additive respiratory depression from THC compounds the risk. This combination should be avoided.
Can cannabis replace oxycodone for pain management?
Some patients and researchers are exploring cannabis as an alternative or adjunct to opioids for chronic pain. However, transitioning from oxycodone to cannabis should only be done under close medical supervision, with gradual opioid tapering. Abrupt discontinuation of oxycodone can cause dangerous withdrawal. This transition is not appropriate for all patients or pain conditions.
What should I do if someone who takes oxycodone seems too sedated after using cannabis?
Check their breathing rate (less than 12 breaths per minute is concerning, less than 8 is an emergency). Try to wake them with a firm sternum rub. If they are difficult to arouse or breathing slowly, call 911 immediately. Administer naloxone (Narcan) if available. Place them in the recovery position (on their side) to prevent aspiration.